Fibroblast fiber contraction: Role of C and Rho kinase in activation by thromboxane A2

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Nobe, Hiromi ^a,b   Nobe, Koji ^a,b   Paul, Richard J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Collagen matrix; Signal transduction; Wound repair

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CALCIUM ION; CALPHOSTIN C; CYCLOPIAZONIC ACID; CYTOCHALASIN D; GROWTH FACTOR; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NEUROTRANSMITTER; PHOSPHOLIPID; PROTEIN KINASE C; RHO KINASE; RHO KINASE INHIBITOR; THROMBOXANE A2; THROMBOXANE A2 DERIVATIVE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; COLLAGEN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FETAL CALF SERUM; FIBROBLAST; GROWTH REGULATION; MOUSE; MUSCLE FIBER CONTRACTION; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; THROMBOGENESIS; WOUND HEALING;

ANIMALIA;

EID: 0242510041     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00067.2003     Document Type: Article

References (34)

1. Armstrong RA. Platelet prostanoid receptors. Pharmacol Ther 72: 171-191, 1996.
2. Batchelor TJ, Sadaba JR, Ishola A, Pacaud P, Munsch CM, and Beech DJ. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol 132: 302-308, 2001.
3. Bell E, Ivarsson B, and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76: 1274-1278, 1979.
4. Dorn GW, Becker MW, and Davis MG. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 267: 24897-24905, 1992.
5. Ehrlich HP and Rittenberg T. Differences in the mechanism for high- versus moderate-density fibroblast-populated collagen lattice contraction. J Cell Physiol 185: 432-439, 2000.
6. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol 10: 362-365, 2000.
7. Grinnell F, Ho CH, Lin YC, and Skuta G. Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices. J Biol Chem 274: 918-923, 1999.
8. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
9. Gschwendt M, Kittstein W, and Marks F. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett 338: 85-88, 1994.
10. Hamberg M, Svensson J, and Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994-2998, 1975.
11. Kobayashi E, Nakano H, Morimoto M, and Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989.
12. Kolodney MS and Elson EL. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 268: 23850-23855, 1993.
13. Kolodney MS and Wysolmerski RB. Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study. J Cell Biol 117: 73-82, 1992.
14. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276: 75-81, 1997.
15. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, and Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197, 1993.
16. 2. Ciba Found Symp 78: 165-183, 1980.
17. Montesano R and Orci L. Transforming growth factor-β stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 85: 4894-4897, 1988.
18. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
19. 20 phosphorylation. Am J Physiol Cell Physiol 284: C599-C606, 2003.
20. 2+ stores in regulation of isometric force in NIH 3T3 fibroblast fibres. J Physiol 529: 669-679, 2000.
21. Obara K, Nikcevic G, Pestic L, Nowak G, Lorimer DD, Guerriero V Jr, Elson EL, Paul RJ, and de Lanerolle P. Fibroblast contractility without an increase in basal myosin light chain phosphorylation in wild-type cells and cells expressing the catalytic domain of myosin light chain kinase. J Biol Chem 270: 18734-18737, 1995.
22. i and contractility in a reconstituted fibroblast fiber. Am J Physiol Cell Physiol 279: C785-C796, 2000.
23. Parizi M, Howard EW, and Tomasek JJ. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 254: 210-220, 2000.
24. Rasmussen H, Barrett P, Takuwa Y, and Apfeldorf W. Calcium in the regulation of aldosterone secretion and vascular smooth muscle contraction. Hypertension 10: 123-126, 1987.
25. Ridley AJ and Hall A. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J 13: 2600-2610, 1994.
26. Saitoh M, Ishikawa T, Matsushima S, Naka M, and Hidaka H. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 262: 7796-7801, 1987.
27. Shen X, Bhargava V, Wodicka GR, Doerschuk CM, Gunst SJ, and Tepper RS. Greater airway narrowing in immature than in mature rabbits during methacholine challenge. J Appl Physiol 81: 2637-2643, 1996.
28. Somlyo AP and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994. [Corrigenda. Nature 372: December 1994, p. 812]
29. Somlyo AP and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994. [Corrigenda. Nature 372: December 1994, p. 812]
30. Takayama Y and Mizumachi K. Effects of lactoferrin on collagen gel contractile activity and myosin light chain phosphorylation in human fibroblasts. FEBS Lett 508: 111-116, 2001.
31. Tanaka T, Ohmura T, Yamakado T, and Hidaka H. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives. Mol Pharmacol 22: 408-412, 1982.
32. 2+/calmodulin-dependent protein kinase II. J Biol Chem 265: 4315-4320, 1990.
33. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
34. i2 in phospholipid vesicles. Mol Pharmacol 46: 808-816, 1994.